Valuation: Prince Pharmaceutical Co., Ltd.

Market Cap 1.11B 34.17M 29.86M 27.55M 25.4M 47.87M 3.29B 48.93M 329M 130M 1.61B 128M 126M 5.55B P/E 2024
-15x
P/E 2025 11.9x
Enterprise Value 1.38B 42.48M 37.13M 34.26M 31.58M 59.52M 4.09B 60.84M 409M 161M 2B 160M 156M 6.9B EV / Sales 2024
1.68x
EV / Sales 2025 1.33x
Free-Float
42.7%
Yield 2024 *
-
Yield 2025 1.61%
1 week-0.17%
Current month+1.51%
1 month-1.79%
3 months-1.14%
6 months-1.47%
Current year-2.73%
1 week 28.85
Extreme 28.85
31.7
1 month 27.55
Extreme 27.55
32.5
Current year 26.5
Extreme 26.5
32.5
1 year 24.25
Extreme 24.25
35.85
3 years 18.5
Extreme 18.5
41.55
5 years 18.5
Extreme 18.5
75.2
10 years 18.5
Extreme 18.5
75.2
Manager TitleAgeSince
Chief Executive Officer - 2021-12-09
Director of Finance/CFO - 2008-06-01
Chief Tech/Sci/R&D Officer - 1991-01-31
Director TitleAgeSince
Director/Board Member - 2023-01-17
Director/Board Member - 2023-01-17
Chairman - -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.17%+15.46%-22.34% 34.17M
+1.64%+1.74%+33.88%+82.16% 13.23B
-4.30%-1.16%-31.43%+247.99% 7.86B
+1.21%+8.06%-13.20%-51.38% 2.49B
-8.34%-2.55% - - 1.42B
+1.08%-2.88%-79.18%-66.14% 1.41B
-2.95%+8.11%-24.57%-20.04% 1.33B
+0.33%+0.67%+20.88%+47.58% 1.24B
-3.07%-8.82%+29.34%-11.12% 1.24B
-8.20%-13.23%-66.15%-70.73% 980M
Average -2.26%-0.82%-12.77%+15.11% 3.12B
Weighted average by Cap. -1.11%+1.97%+0.75%+92.68%

Financials

2024 2025
Net sales 690M 21.29M 18.61M 17.17M 15.83M 29.83M 2.05B 30.49M 205M 80.72M 1B 79.97M 78.21M 3.46B 1.06B 32.59M 28.48M 26.28M 24.23M 45.66M 3.14B 46.68M 314M 124M 1.54B 122M 120M 5.29B
Net income -53.54M -1.65M -1.44M -1.33M -1.23M -2.31M -159M -2.37M -15.93M -6.26M -77.93M -6.2M -6.07M -268M 96.32M 2.97M 2.6M 2.4M 2.21M 4.16M 286M 4.26M 28.65M 11.27M 140M 11.16M 10.92M 483M
Net Debt 358M 11.05M 9.65M 8.91M 8.21M 15.48M 1.06B 15.82M 106M 41.88M 521M 41.49M 40.58M 1.79B 269M 8.31M 7.27M 6.7M 6.18M 11.65M 801M 11.91M 80.13M 31.52M 392M 31.22M 30.54M 1.35B
Logo Prince Pharmaceutical Co., Ltd.
Prince Pharmaceutical Co Ltd is a Taiwan-based Company engaged in the manufacture and sale of health food and ingredients. The Company's main business is divided into ingredients business and health food business. The ingredients business currently consists of phlegm dispelling agents, vitamin B1 derivatives, and non-steroidal anti-inflammatory drugs. The health food business is mainly engaged in the original equipment manufacturer (OEM) and original design manufacturer (ODM) of health food products, providing a series of integrated services from product formulation design, research and development to the production and packaging of various dosage forms. The Company sells its products mainly in domestic and overseas markets, including Japan and Korea.
Employees
216
Date Price Change Volume
26-07-17 NT$30.25 0.00% 6,911
26-07-16 NT$30.25 -0.17% 110
26-07-15 NT$30.30 +0.17% 6,032
26-07-14 NT$30.25 0.00% 231
26-07-13 NT$30.25 -0.17% 10,411
  1. Stock Market
  2. Stocks
  3. 6935 Stock